Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

A minor role of asparaginase in predisposing to cerebral venous thromboses in adult acute lymphoblastic leukemia patients.

Roininen S, Laine O, Kauppila M, Vesanen M, Rämet M, Sinisalo M, Jantunen E, Säily M, Räty R, Elonen E, Wartiovaara-Kautto U.

Cancer Med. 2017 Jun;6(6):1275-1285. doi: 10.1002/cam4.1094. Epub 2017 May 15.

2.

Complement and c4 null alleles in severe chronic adult periodontitis.

Seppänen M, Lokki ML, Notkola IL, Mattila K, Valtonen V, Nieminen A, Vesanen M, Asikainen S, Meri S.

Scand J Immunol. 2007 Feb;65(2):176-81.

3.

Severe periodontitis enhances macrophage activation via increased serum lipopolysaccharide.

Pussinen PJ, Vilkuna-Rautiainen T, Alfthan G, Palosuo T, Jauhiainen M, Sundvall J, Vesanen M, Mattila K, Asikainen S.

Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2174-80. Epub 2004 Sep 23.

PMID:
15388525
4.

Periodontitis decreases the antiatherogenic potency of high density lipoprotein.

Pussinen PJ, Jauhiainen M, Vilkuna-Rautiainen T, Sundvall J, Vesanen M, Mattila K, Palosuo T, Alfthan G, Asikainen S.

J Lipid Res. 2004 Jan;45(1):139-47. Epub 2003 Sep 16.

5.

Effect of treating periodontitis on C-reactive protein levels: a pilot study.

Mattila K, Vesanen M, Valtonen V, Nieminen M, Palosuo T, Rasi V, Asikainen S.

BMC Infect Dis. 2002 Dec 10;2:30. Epub 2002 Dec 10.

6.

Antigenically diverse reference strains and autologous strains of Actinobacillus actinomycetemcomitans are equally efficient antigens in enzyme-linked immunosorbent assay analysis.

Vilkuna-Rautiainen T, Pussinen PJ, Mattila K, Vesanen M, Ahman H, Doğan B, Asikainen S.

J Clin Microbiol. 2002 Dec;40(12):4640-5.

7.

Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.

Sanders RW, Vesanen M, Schuelke N, Master A, Schiffner L, Kalyanaraman R, Paluch M, Berkhout B, Maddon PJ, Olson WC, Lu M, Moore JP.

J Virol. 2002 Sep;76(17):8875-89.

8.

Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein.

Schülke N, Vesanen MS, Sanders RW, Zhu P, Lu M, Anselma DJ, Villa AR, Parren PW, Binley JM, Roux KH, Maddon PJ, Moore JP, Olson WC.

J Virol. 2002 Aug;76(15):7760-76.

9.

Open-label phase II trial of amprenavir, abacavir, and fixed-dose zidovudine/lamivudine in newly and chronically HIV-1--infected patients.

Kost RG, Hurley A, Zhang L, Vesanen M, Talal A, Furlan S, Caldwell P, Johnson J, Smiley L, Ho D, Markowitz M.

J Acquir Immune Defic Syndr. 2001 Apr 1;26(4):332-9.

PMID:
11317074
10.

Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue.

Talal AH, Monard S, Vesanen M, Zheng Z, Hurley A, Cao Y, Fang F, Smiley L, Johnson J, Kost R, Markowitz MH.

J Acquir Immune Defic Syndr. 2001 Jan 1;26(1):1-7.

PMID:
11176263
11.

An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.

Jin X, Ogg G, Bonhoeffer S, Safrit J, Vesanen M, Bauer D, Chen D, Cao Y, Demoitie MA, Zhang L, Markowitz M, Nixon D, McMichael A, Ho DD.

Mol Med. 2000 Sep;6(9):803-9.

12.

Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia.

Binley JM, Clas B, Gettie A, Vesanen M, Montefiori DC, Sawyer L, Booth J, Lewis M, Marx PA, Bonhoeffer S, Moore JP.

Virology. 2000 Apr 25;270(1):237-49.

13.

Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy.

Zhang L, Lewin SR, Markowitz M, Lin HH, Skulsky E, Karanicolas R, He Y, Jin X, Tuttleton S, Vesanen M, Spiegel H, Kost R, van Lunzen J, Stellbrink HJ, Wolinsky S, Borkowsky W, Palumbo P, Kostrikis LG, Ho DD.

J Exp Med. 1999 Sep 6;190(5):725-32.

14.
15.

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.

Zhang L, Ramratnam B, Tenner-Racz K, He Y, Vesanen M, Lewin S, Talal A, Racz P, Perelson AS, Korber BT, Markowitz M, Ho DD.

N Engl J Med. 1999 May 27;340(21):1605-13.

16.

Molecular tracking of an Human Immunodeficiency Virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA but not mRNA following early combination antiretroviral therapy.

Nixon DF, Douek D, Kuebler PJ, Jin X, Vesanen M, Bonhoeffer S, Cao Y, Koup RA, Ho DD, Markowitz M.

Immunol Lett. 1999 Mar;66(1-3):219-28.

PMID:
10203058
17.

The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses.

Markowitz M, Vesanen M, Tenner-Racz K, Cao Y, Binley JM, Talal A, Hurley A, Jin X, Chaudhry MR, Yaman M, Frankel S, Heath-Chiozzi M, Leonard JM, Moore JP, Racz P, Nixon DF, Ho DD.

J Infect Dis. 1999 Mar;179(3):527-37. Erratum in: J Infect Dis 1999 May;179(5):1315. J X [corrected to Jin X].

PMID:
9952358
18.
19.

Decay characteristics of HIV-1-infected compartments during combination therapy.

Perelson AS, Essunger P, Cao Y, Vesanen M, Hurley A, Saksela K, Markowitz M, Ho DD.

Nature. 1997 May 8;387(6629):188-91.

PMID:
9144290
21.
22.

Human spumaretrovirus in the etiology of sudden hearing loss.

Pyykkö I, Vesanen M, Asikainen K, Koskiniemi M, Airaksinen L, Vaheri A.

Acta Otolaryngol. 1994 Mar;114(2):224. No abstract available.

PMID:
8203207
23.

Morphological differentiation of human SH-SY5Y neuroblastoma cells inhibits human immunodeficiency virus type 1 infection.

Vesanen M, Salminen M, Wessman M, Lankinen H, Sistonen P, Vaheri A.

J Gen Virol. 1994 Jan;75 ( Pt 1):201-6.

PMID:
8113728
24.

Identification of human type D retrovirus as a contaminant in a neuroblastoma cell line.

Asikainen K, Vesanen M, Kuittinen T, Vaheri A.

Arch Virol. 1993;129(1-4):357-61.

PMID:
8385922
25.

Human spumaretrovirus in the etiology of sudden hearing loss.

Pyykkö I, Vesanen M, Asikainen K, Koskiniemi M, Airaksinen L, Vaheri A.

Acta Otolaryngol. 1993 Jan;113(1):109-12. Erratum in: Acta Otolaryngol. 1994 Mar;114(2):224.

PMID:
8382898
27.
28.
29.

Persistent inapparent HIV-1 infection of human neuroblastoma cells.

Vesanen M, Linna T, Vaheri A.

Arch Virol. 1991;120(3-4):253-61.

PMID:
1958129
30.

Bovine steroid hormone and SHBG concentrations postpartum and during the oestrous cycle.

Vesanen M, Isomaa V, Bolton NJ, Alanko M, Vihko R.

Acta Vet Scand. 1990;31(4):459-69.

PMID:
2099624
31.

Supplemental Content

Loading ...
Support Center